Company profile: Corthera
1.1 - Company Overview
Company description
- Provider of biopharmaceutical acquisition, development and commercialization of therapies for illnesses in the acute care setting; lead product candidate relaxin is being evaluated in a global phase 2/3 clinical trial for acute decompensated heart failure.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Corthera
Xention
HQ: United Kingdom
Website
- Description: Provider of ion channel-modulating drug discovery and development, offering therapeutics for atrial fibrillation, overactive bladder, pain, and autoimmune diseases.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Xention company profile →
Soley Therapeutics
HQ: United States
Website
- Description: Provider of AI-driven drug discovery solutions combining molecular and cellular response detection, including a proprietary platform that decodes cellular responses to predict cell fate, cellular sensing and anticipatory biology methods, and stress-modulating/tumor-targeting therapeutic discovery.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Soley Therapeutics company profile →
Endonovo Therapeutics
HQ: United States
Website
- Description: Provider of off-the-shelf regenerative products and non-invasive electroceutical therapies, including SofPulse, a targeted microcurrent device for reducing swelling and accelerating recovery after surgery; PEMF-based treatments for cardiovascular and CNS disorders; a clinical trial in ischemic cardiomyopathy; and TVEMF technologies to mobilize stem cells and promote regeneration.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Endonovo Therapeutics company profile →
Field Medical
HQ: United States
Website
- Description: Provider of pulsed field ablation (PFA) technologies that use micro-bursts of energy delivered via catheter to disrupt cardiac cells without heat or cold, aiming to improve cardiac ablation treatments. Offerings include FieldForce Ventricular PFA for ventricular arrhythmia ablation, currently in first-in-human trials.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Field Medical company profile →
CinCor Pharma
HQ: United States
Website
- Description: Provider of clinical-stage biopharmaceutical research and development focused on cardiovascular, metabolic, and kidney diseases, advancing promising clinical candidates toward marketing approval, including CIN-107, a novel aldosterone synthase inhibitor.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full CinCor Pharma company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Corthera
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Corthera
2.2 - Growth funds investing in similar companies to Corthera
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Corthera
4.2 - Public trading comparable groups for Corthera
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →